These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25044856)

  • 1. Angiopep-conjugated electro-responsive hydrogel nanoparticles: therapeutic potential for epilepsy.
    Ying X; Wang Y; Liang J; Yue J; Xu C; Lu L; Xu Z; Gao J; Du Y; Chen Z
    Angew Chem Int Ed Engl; 2014 Nov; 53(46):12436-40. PubMed ID: 25044856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroresponsive Nanoparticles Improve Antiseizure Effect of Phenytoin in Generalized Tonic-Clonic Seizures.
    Wang Y; Ying X; Chen L; Liu Y; Wang Y; Liang J; Xu C; Guo Y; Wang S; Hu W; Du Y; Chen Z
    Neurotherapeutics; 2016 Jul; 13(3):603-13. PubMed ID: 27137202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.
    Xin H; Jiang X; Gu J; Sha X; Chen L; Law K; Chen Y; Wang X; Jiang Y; Fang X
    Biomaterials; 2011 Jun; 32(18):4293-305. PubMed ID: 21427009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of seizure activity on free extracellular phenytoin concentrations in amygdala-kindled rats.
    Potschka H; Baltes S; Fedrowitz M; Löscher W
    Neuropharmacology; 2011; 61(5-6):909-17. PubMed ID: 21736886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug transporters in the epileptic brain.
    Löscher W
    Epilepsia; 2007; 48 Suppl 1():8-13. PubMed ID: 17316407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
    Ke W; Shao K; Huang R; Han L; Liu Y; Li J; Kuang Y; Ye L; Lou J; Jiang C
    Biomaterials; 2009 Dec; 30(36):6976-85. PubMed ID: 19765819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles.
    Xin H; Sha X; Jiang X; Zhang W; Chen L; Fang X
    Biomaterials; 2012 Nov; 33(32):8167-76. PubMed ID: 22889488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoproteomics-based reconstruction of in vivo P-glycoprotein function at blood-brain barrier and brain distribution of substrate verapamil in pentylenetetrazole-kindled epilepsy, spontaneous epilepsy, and phenytoin treatment models.
    Uchida Y; Ohtsuki S; Terasaki T
    Drug Metab Dispos; 2014 Oct; 42(10):1719-26. PubMed ID: 25061162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide-based hydrogel nanoparticles as effective drug delivery agents.
    Ischakov R; Adler-Abramovich L; Buzhansky L; Shekhter T; Gazit E
    Bioorg Med Chem; 2013 Jun; 21(12):3517-22. PubMed ID: 23566763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-glycoprotein alters blood-brain barrier penetration of antiepileptic drugs in rats with medically intractable epilepsy.
    Ma A; Wang C; Chen Y; Yuan W
    Drug Des Devel Ther; 2013; 7():1447-54. PubMed ID: 24348021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
    Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
    Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery.
    Ye Y; Sun Y; Zhao H; Lan M; Gao F; Song C; Lou K; Li H; Wang W
    Int J Pharm; 2013 Dec; 458(1):110-7. PubMed ID: 24126038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs.
    Cucullo L; Hossain M; Rapp E; Manders T; Marchi N; Janigro D
    Epilepsia; 2007 Mar; 48(3):505-16. PubMed ID: 17326793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of antiepileptic drug efficacy: the use of intracerebral microdialysis to monitor biophase concentrations.
    Clinckers R; Smolders I; Vermoesen K; Michotte Y; Danhof M; Voskuyl R; Della Pasqua O
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1267-77. PubMed ID: 19611404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose adjustment of phenytoin for comedication in Japanese patients with epilepsy.
    Fukuoka N; Uno J; Tsukamoto T; Houchi H; Kimura M; Morita S
    Ther Drug Monit; 2009 Feb; 31(1):57-62. PubMed ID: 19077928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A method for evaluating nanoparticle transport through the blood-brain barrier in vitro.
    Guarnieri D; Muscetti O; Netti PA
    Methods Mol Biol; 2014; 1141():185-99. PubMed ID: 24567140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retro-inverso isomer of Angiopep-2: a stable d-peptide ligand inspires brain-targeted drug delivery.
    Wei X; Zhan C; Chen X; Hou J; Xie C; Lu W
    Mol Pharm; 2014 Oct; 11(10):3261-8. PubMed ID: 24673510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The blood-brain barrier and epilepsy.
    Oby E; Janigro D
    Epilepsia; 2006 Nov; 47(11):1761-74. PubMed ID: 17116015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma.
    Huang S; Li J; Han L; Liu S; Ma H; Huang R; Jiang C
    Biomaterials; 2011 Oct; 32(28):6832-8. PubMed ID: 21700333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats.
    van Vliet EA; Zibell G; Pekcec A; Schlichtiger J; Edelbroek PM; Holtman L; Aronica E; Gorter JA; Potschka H
    Neuropharmacology; 2010 Feb; 58(2):404-12. PubMed ID: 19786037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.